Welcome Contact

Email: sales@sex-pharm.com

ADD: 0805, No. 24, Dongming Rd, Xiamen, China.

Fnose--Specifically R&D for heart disease!

Consignment note

  Scott Alba, USA, order No.:SE806901 has been shipped.

  Peter Alexander, USA, order No.:SE806907 has been shipped.

  Darren Brown, GB, order No.:SE806911 has been shipped.

  Yehudi Ben, USA, order No.:SE806942 has been shipped.

  Xavier naidoo, ES, order No.:SE806939 has been shipped.

  Trevor Wright, IT, order No.:SE806969 has been shipped.

  Xavier Scott, USA, order No.:SE806949 has been shipped.

  Wythe Gino, FR, order No.:SE806937 has been shipped.

  Dick Gaby, DE, order No.:SE806958 has been shipped.

  Derrick, DE, order No.:SE807039 has been shipped.

  Xenos Timothy, USA, order No.:SE807136 has been shipped.

  Ximen Vern, USA, order No.:SE807145 has been shipped.

  Udeh Vernon, KR, order No.:SE807255 has been shipped.

  Ulrich Warren, KR, order No.:SE807265 has been shipped.

  Leif Stuart, MY, order No.:SE807368 has been shipped.

  Lynn Randall, MY, order No.:SE807439 has been shipped.

  Louis Patrick, USA, order No.:SE807440 has been shipped.

  Levi Matthew, USA, order No.:SE807521 has been shipped.

  Dana Lorin, USA, order No.:SE807611 has been shipped.

  York green, GB, order No.:SE807739 has been shipped.

Invicorp

Current pharmacotherapy for erectile dysfunction includes oral, transurethral and injectable intracavernosal treatments. Invicorp, an autoinjectable formulation of vasoactive intestinal polypeptide (VIP), in combination with the adrenergic drug phentolamine mesylate (PMS) and sexual stimulation, provides an effective therapy for erectile dysfunction patients that is essentially free of troublesome side effects and cumbersome delivery methods. Clinical data indicate that the efficacy and local tolerability profile of Invicorp compare favorably with currently used injectable therapies. The product has already received marketing authorization in Denmark, which has been chosen as the Reference Member State for the Mutual Recognition Procedure in Europe, as well as in England. Additionally, Invicorp has been approved in New Zealand. The most frequently reported side effect was transient facial flushing, which typically subsided within minutes after use.

Back Homepage